FFA
BEAM icon

Farther Finance Advisors’s Beam Therapeutics BEAM Stock Holding History

Farther Finance Advisors’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$88.2K Sell
3,608
-5
-0.1% -$139 ﹤0.01% 2967
2026
Q2 		$124K Buy
3,613
+3,266
+941% +$98.6K ﹤0.01% 2554
2026
Q1 		$8.4K Buy
347
+309
+813% +$8.57K ﹤0.01% 4218
2025
Q4 		$1.05K Buy
38
+4
+12% +$102 ﹤0.01% 4896
2025
Q3 		$825 Sell
34
-7
-17% -$139 ﹤0.01% 4423
2025
Q2 		$697 Sell
41
-5
-11% -$87 ﹤0.01% 3977
2025
Q1 		$811 Buy
46
+10
+28% +$262 ﹤0.01% 3681
2024
Q4 		$893 Sell
36
-10
-22% -$255 ﹤0.01% 3289
2024
Q3 		$1.13K Hold
46
– – ﹤0.01% 3207
2024
Q2 		$1.06K Sell
46
-4
-8% -$98 ﹤0.01% 3058
2024
Q1 		$1.63K Buy
50
+23
+85% +$717 ﹤0.01% 2572
2023
Q4 		$735 Buy
27
+21
+350% +$522 ﹤0.01% 2846
2023
Q3 		$144 Buy
+6
New +$161 ﹤0.01% 2510

Other funds holding BEAM

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors's BEAM Position: Q3 2026 in Review

Farther Finance Advisors reduced its Beam Therapeutics (BEAM) stake by 0.14% in Q3 2026, selling an estimated $139 and leaving 3,608 shares worth $88.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2967.

Farther Finance Advisors first reported a position in BEAM in Q3 2023 and has held it in 13 quarters since. The position peaked at $124K in Q2 2026. 4 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • Farther Finance Advisors held 3,608 shares of Beam Therapeutics worth $88.2K as of Q3 2026.
  • Farther Finance Advisors sold 5 Beam Therapeutics shares in Q3 2026, an estimated $139.
  • Beam Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2967 holding.
  • Farther Finance Advisors first reported a position in Beam Therapeutics in Q3 2023 and has held it in 13 quarters since.
  • Farther Finance Advisors's Beam Therapeutics position peaked at $124K in Q2 2026.
  • 4 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.